Antimicrobial-resistance (AMR) is a growing threat especially to critically ill patients, because treatment failure can have serious consequences. MRSA has been a major concern in Japanese hospitals, however, emerging the drug-resistant pathogens that comprise VRE, MDRP or ESBL have been reported as nosocomial infectious pathogens. To control antimicrobial-resistance, antimicrobial therapy according to local sensitivity result and multidisciplinary management is necessary. CDC recommends 12 steps to prevent AMR among hospitalized patients, which included prevent infection, diagnose and treat infection effectively, use antimicrobials wisely, and prevent transmission. Infectious diseases experts, who are far lacking in Japan, may play a key role to achieve these recommendations.